🎉 M&A multiples are live!
Check it out!

Gelteq Valuation Multiples

Discover revenue and EBITDA valuation multiples for Gelteq and similar public comparables like Peptron, Schott Pharma, and Starpharma.

Gelteq Overview

About Gelteq

Gelteq Ltd is a clinical and science-based company that is focused on developing and commercializing white-label gel-based delivery solutions to preserve the simplicity, accessibility and efficacy of oral delivery without the impediments traditionally associated with other oral delivery methods, with prescription drugs, nutraceuticals, pet care, and other products. It is engaged in the development and testing of a gel-based delivery system for humans and pets. Its principal products are edible gels.


Founded

2018

HQ

United States of America
Employees

20

Website

gelteq.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$11.2M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Gelteq Financials

Gelteq has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Gelteq achieved revenue of n/a and an EBITDA of -$1.7M.

Gelteq expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Gelteq valuation multiples based on analyst estimates

Gelteq P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.1M n/a XXX XXX XXX
Gross Profit $0.1M $31K XXX XXX XXX
Gross Margin 66% Infinity% XXX XXX XXX
EBITDA -$1.9M -$1.7M XXX XXX XXX
EBITDA Margin -2350% -Infinity% XXX XXX XXX
Net Profit -$3.4M -$3.5M XXX XXX XXX
Net Margin -4219% -Infinity% XXX XXX XXX
Net Debt $1.3M $2.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Gelteq Stock Performance

As of April 15, 2025, Gelteq's stock price is $1.

Gelteq has current market cap of $8.8M, and EV of $11.2M.

See Gelteq trading valuation data

Gelteq Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$11.2M $8.8M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Gelteq Valuation Multiples

As of April 15, 2025, Gelteq has market cap of $8.8M and EV of $11.2M.

Gelteq's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Gelteq's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Gelteq and 10K+ public comps

Gelteq Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $11.2M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -6.4x XXX XXX XXX
P/E -2.5x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -9.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Gelteq Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Gelteq Valuation Multiples

Gelteq's NTM/LTM revenue growth is n/a

Gelteq's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Gelteq's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Gelteq's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Gelteq and other 10K+ public comps

Gelteq Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -100% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth -7% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Gelteq Public Comps

See public comps and valuation multiples for Drug Delivery Systems comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
LTR Pharma XXX XXX XXX XXX XXX XXX
Starpharma XXX XXX XXX XXX XXX XXX
Schott Pharma XXX XXX XXX XXX XXX XXX
Nanoform XXX XXX XXX XXX XXX XXX
Peptron XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Gelteq M&A and Investment Activity

Gelteq acquired  XXX companies to date.

Last acquisition by Gelteq was  XXXXXXXX, XXXXX XXXXX XXXXXX . Gelteq acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Gelteq

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Gelteq

When was Gelteq founded? Gelteq was founded in 2018.
Where is Gelteq headquartered? Gelteq is headquartered in United States of America.
How many employees does Gelteq have? As of today, Gelteq has 20 employees.
Who is the CEO of Gelteq? Gelteq's CEO is Mr. Nathan J. Givoni.
Is Gelteq publicy listed? Yes, Gelteq is a public company listed on NAS.
What is the stock symbol of Gelteq? Gelteq trades under GELS ticker.
When did Gelteq go public? Gelteq went public in 2024.
Who are competitors of Gelteq? Similar companies to Gelteq include e.g. LTR Pharma, Starpharma, Schott Pharma, Nanoform.
What is the current market cap of Gelteq? Gelteq's current market cap is $8.8M
Is Gelteq profitable? Yes, Gelteq is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.